SINK SIDE
NOTESSKIN-CARE DECISIONPRACTICAL CALL

U.S. ROUTINE CONTEXT · PRACTICAL CALL

Address bumpy “chicken skin” without a sticky body lotion

Compare appearance-focused body products by actives, finish, frequency, and adherence.

NOTE 01

OUR SINK-SIDE CALL

The route we would take.

Use one smoothing body active slowly and consistently

NOTE 02

Where the call changes.

CHOOSE DIFFERENTLY WHEN

  • Daily exfoliation can create irritation that looks worse than the original bumps.
  • Painful or inflamed bumps should not be self-classified from a lotion comparison.

WHAT WE ARE NOT CLAIMING

  • There is no standardized, comparable measure of greasiness, stickiness, stinging, absorption, film, or pilling.

NOTE 03

HOW TO READ THIS NOTE

Evidence without theater.

This page makes an editorial call from documented context. It does not claim a product was owned, used, ranked, or independently tested. Manufacturer statements never become our results.

EVIDENCE TRAIL

What the sources carry — and what the desk decides.

The linked sources support product status, labeling, or professional boundaries. They do not prove the editorial winner and they do not stand in for an owned test.

EDITORIAL JUDGMENT

Use one smoothing body active slowly and consistently

A reasoned course of action; not a product result measured by the source.
BOUNDARY OF THE CALL

Daily exfoliation can create irritation that looks worse than the original bumps.

There is no standardized, comparable measure of greasiness, stickiness, stinging, absorption, film, or pilling.

Primary and professional sources in the record

  1. Is It a Cosmetic, a Drug, or Both? (Or Is It Soap?)U.S. Food and Drug Administration
  2. Cosmetics Labeling ClaimsU.S. Food and Drug Administration
  3. Summary of Cosmetics Labeling RequirementsU.S. Food and Drug Administration
  4. 21 CFR Part 701 — Cosmetic LabelingOffice of the Federal Register / eCFR
  5. 21 CFR Part 740 — Cosmetic Product Warning StatementsOffice of the Federal Register / eCFR
  6. FDA Adverse Event Monitoring System (AEMS)U.S. Food and Drug Administration
  7. KP creams and lotions leave bedding and body stickyu/Own_Island5749 — Reddit r/keratosis
Data and test conditions still required
Product function and category

Document against the current U.S. product version; keep missing or non-comparable information visibly open.

Ingredient list for the current version

Document against the current U.S. product version; keep missing or non-comparable information visibly open.

Body area and directions

Document against the current U.S. product version; keep missing or non-comparable information visibly open.

Amount, contact time, and frequency

Document against the current U.S. product version; keep missing or non-comparable information visibly open.

Sensory feel over time

Document against the current U.S. product version; keep missing or non-comparable information visibly open.

Performance under realistic use

Document against the current U.S. product version; keep missing or non-comparable information visibly open.

Tolerance protocol and stop criteria

Document against the current U.S. product version; keep missing or non-comparable information visibly open.

Assess body care and textile transfer

Define and retain the conditions, date, material, and outcome before presenting any owned observation.

Track exfoliation dose, frequency, and response

Define and retain the conditions, date, material, and outcome before presenting any owned observation.

Separate cosmetic skin care from medical review

Define and retain the conditions, date, material, and outcome before presenting any owned observation.